KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Assets Average (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Assets Average for 16 consecutive years, with $10.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average rose 105.52% to $10.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $10.1 billion, a 105.52% increase, with the full-year FY2025 number at $10.0 billion, up 106.61% from a year prior.
  • Assets Average was $10.1 billion for Q4 2025 at Bio-Rad Laboratories, up from $10.0 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $17.5 billion in Q3 2021 to a low of $289.4 million in Q1 2024.
  • A 5-year average of $10.5 billion and a median of $11.3 billion in 2021 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: plummeted 97.87% in 2024, then skyrocketed 105.52% in 2025.
  • Bio-Rad Laboratories' Assets Average stood at $10.2 billion in 2021, then rose by 25.81% to $12.8 billion in 2022, then crashed by 52.34% to $6.1 billion in 2023, then decreased by 19.04% to $4.9 billion in 2024, then surged by 105.52% to $10.1 billion in 2025.
  • Per Business Quant, the three most recent readings for BIO's Assets Average are $10.1 billion (Q4 2025), $10.0 billion (Q3 2025), and $4.9 billion (Q4 2024).